C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 261/20 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2470591
The present invention relates to novel LXR ligands of Formula (I) and the pharmaceutically acceptable salts and esters thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.
La présente invention concerne de nouveaux ligands LXR de la formule (1) et les sels et esters pharmaceutiquement acceptables de ces derniers, qui sont utilisés dans le traitement d'états dyslipidémiques, en particulier de niveaux altérés de cholestérol HDL.
Adams Alan D.
Green Ahren
Huang Shaei Y.
Jones A. Brian
Tse Bruno
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Therapeutic compounds for treating dyslipidemic conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compounds for treating dyslipidemic conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds for treating dyslipidemic conditions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1541628